NeuMedics is actively  listed on crowd funding sites, Healthios, Gust, and Angel MD. Proceeds from these sources will be used to advance NeuMedics development program and provide  data  that is both conclusive and can translate into clinical  trials.

NeuMedics intends to commit 10-15% of its outstanding shares and use the funds to complete  :

• Characterization of NM108 as an eye drop
• Completion of pivotal pre clinical “killer experiments”, necessary to support an IND

Individuals who are interested in finding out more should contact the Crowdfunding broker for the respective site, or contact NeuMedics. NeuMedics will only release  a  full company profile, including investment information, to qualified  investors signed up  through a Crowdfunding portal.